30 Tablets (Lacosamide 100 mg)
Description not available.*
Lacosamide Tablet, Film Coated
Product Images NDC 46708-174
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 46708-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
30 Tablets (Lacosamide 150 mg)
30 Tablets (Lacosamide 200 mg)
This appears to be a description of a medication called Lacosanide Tablets, which is classified as a prescription drug and should only be taken as advised by a licensed healthcare provider. The medication is packaged in specific vials with the code NOC 46708-174-30 and should be stored at 25°C (77°F). The remaining text is not clear and appears to be related to packaging and usage instructions.*
30 Tablets (Lacosamide 50 mg)
Figure1 (Lacosamide Figure 1)
Figure2 (Lacosamide Figure 2)
This is a graph showing the responder rate for Lacosamide and placebo groups in studies 2,3, and 4. It indicates the proportion of patients who showed improvement or worsening. The graph shows the percentage of patients categorized by responder rate for each group. The y-axis has the percentage of patients ranging from 0-100, whereas the x-axis represents different Lacosamide dosages and a placebo group. There is insufficient information to determine what the drug Lacosamide is used for.*
Structure (Lacosamide Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
